COLL vs TRV · P/E 17, rev $181.9M vs P/E 14, rev $48.83B
Collegium Pharmaceutical Inc (COLL) versus The Travelers Companies Inc (TRV) — a side-by-side from cached financials, not a winner call.
Collegium Pharmaceutical Inc (COLL) is a drug manufacturers - specialty & generic company listed on NASDAQ.
The Travelers Companies Inc (TRV) is a insurance - property & casualty company listed on US.
Latest reported COLL revenue for 2024-12-31 was $181.9M. Net income was $69.2M. Revenue was up 14.2% from 2024-09-30 to 2024-12-31. COLL currently screens at market cap $1.12B and trailing P/E 16.8.
Latest reported TRV revenue for 2025-12-31 was $48.83B. Net income was $6.29B. Revenue was up 5.2% from 2024-12-31 to 2025-12-31. TRV currently screens at market cap $59.84B and trailing P/E 14.4.
COLL currently screens at market cap $1.12B and trailing P/E 16.8. TRV currently screens at market cap $59.84B and trailing P/E 14.4.
Not investment advice. Open the COLL and TRV stock pages for the full models.
Not investment advice.